Shares in Addex Pharmaceuticals trade on the main board at the SWX Swiss Exchange. The stock symbol is: ADXN (ISIN: CH0029850754). As of 30 June 2007 there were 5,862,492 ADXN shares outstanding. Addex had cash of CHF140 million as of December 31, 2007 and received a $22 million upfront payment from its partner Merck & Co., Inc. in January, 2008. As a result, Addex is very well financed and can fund operations through at least 2011. Browse our financial and other corporate documents and our informative webcasts and conference presentations.

We invite you to meet with Addex at these events or contact us to request a meeting or information.

financial calendar

July 28, 2008: 1H08 Financial Results

February 26, 2009: FY08 Financial Results

April 16, 2009: Annual General Meeting